SET Enterprises launches SPI340B℠ service to detect suspicious purchasing patterns among 340B covered entities.

SET Enterprises has introduced SPI340B℠, a service that detects suspicious purchasing patterns among 340B covered entities, healthcare organizations receiving discounted medications under the 340B Drug Pricing Program. SPI340B℠ aims to help pharmaceutical and biotech manufacturers ensure their products are used as intended, only for eligible patients. The service uses proprietary algorithms and models to analyze manufacturers' sales data and identify specific purchasing patterns that signal potential diversion. By detecting such patterns, manufacturers can reduce revenue leakage and minimize investments.

August 02, 2024
9 Articles